Skip to main content

Advertisement

Log in

Chromogenic Medium for Direct Susceptibility Testing of Candida spp. Isolated from Urine

  • Published:
Mycopathologia Aims and scope Submit manuscript

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

Abstract

Currently, there has been an increased frequency of fungal infections. Candida albicans and other Candida spp. have been proven to be major causes for urinary tract infection. Increased resistance to antifungals indicates the need to develop strategies in order to prevent the spread of resistance. Chromogenic medium have been proven to be useful in the detection of yeasts in clinical specimens containing mixed cultures of Candida. The aim of this study was to compare the results of antifungal susceptibility testing with fluconazole and amphotericin B on strains of Candida spp. isolated from urine, conducted on a Mueller–Hinton Agar with Glucose and Methylene Blue (MHAGMB) medium and on a Hicrome Candida® Agar with 2% Glucose (HCAG) medium. We used 40 samples of Candida spp. isolated from urine samples from inpatients and outpatients. The results showed that both media presented high rates of agreement, above 94%. The use of the HCAG medium decreases the release time of the results by 24–48 h, which may be decisive for initiating the correct drug treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Menezes EA, Mendes LG, Cunha FA. Resistência a antifúngicos de Candida tropicalis no Estado do Ceará. Rev Soc Bras Med Trop. 2009;42:354–5.

    Article  PubMed  Google Scholar 

  2. Pfaller MA, Diekema DJ. The epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev. 2007;20:133–63.

    Article  PubMed  CAS  Google Scholar 

  3. Cowen LE, Steinbach WJ. Stress, drugs, and evolution: the role of cellular signaling in fungal drug resistance. Eukariotic Cell. 2008;7:744–64.

    Google Scholar 

  4. Menezes EA, Monteiro MNR, Parente TMA, et al. Frequency and enzymatic activity of Candida albicans isolated from the oral cavity of HIV-positive patients at Fortaleza, Ceará. J Bras Patol Med Lab. 2006;42:253–6.

    Article  CAS  Google Scholar 

  5. Araújo CR, Miranda KC, Passos XS, et al. Identificação das leveduras do gênero Candida por métodos manuais convencionais e pelo método cromógeno CHROMagar Candida. Rev Patologia Tropical. 2005;34:37–42.

    Google Scholar 

  6. Espinel-Ingroff A. Standardized disk diffusion method yeast. Clin Microb Newsl. 2007;29:97–100.

    Article  Google Scholar 

  7. Rubio MC, Gil J, Ramirez OI, Benito R, Rezusta A. Comparison of results obtained by testing with three different agar media and by the NCCLS M27-A method for in vitro testing of fluconazole against Candida spp. J Clin Microbiol. 2003;41:2665–8.

    Article  PubMed  CAS  Google Scholar 

  8. Wayne PA. Clinical and Laboratory Standards Institute (CLSI). Methods for antifungal disk diffusion susceptibility testing of yeasts; approved standard M44-A. 1997.

  9. Tan GL, Peterson EM. CHROMagar Candida medium for direct susceptibility testing of yeast from blood cultures. J Clin Microbiology. 2005;43:1727–31.

    Article  Google Scholar 

  10. García-Martos P, García-Agudo R, Hernándes-Molina JM, et al. Identification de leveduras de interés clínico en el medio de cultivo CHROMagar Candida. Rev Iberoam Micol. 1998;15:131–5.

    PubMed  Google Scholar 

  11. Pujol I, Pastor FJ, Lazéra MS, Guarro J. Evaluation of the Neo-Sensitabs® diffusion method for determining the antifungal susceptibilities of Cryptococcus gattii isolates, using three different agar media. Rev Iberoam Micol. 2008;25:215–20.

    Article  PubMed  Google Scholar 

  12. Kiraz N, Dag I, Oz Y, Yamac M, Kiremitci A, Kasifoglu N. Correlation between broth microdilution and disk difusion methods for antifungal susceptibility testing of caspofungin, voriconazole, amphotericin B, itraconazole and fluconazole against Candida glabrata. J Microbiol Meth. 2010;82:136–40.

    Article  CAS  Google Scholar 

  13. Weinberger M, Sweet S, Leibovici L, Pitlik SD, Samra ZJ. Correlation between candiduria and departmental antibiotic use. J Hosp Infect. 2003;53:183–6.

    Article  PubMed  CAS  Google Scholar 

  14. Colombo AL, Guimarães T. Candiduria: a clinical and therapeutic approach. Rev Soc Bras Med Trop. 2007;40:332–7.

    Article  PubMed  Google Scholar 

  15. Hospenthal DR, Murray CK, Beckius L, Green JA, Dooley DP. Persistence of pigment production by yeast isolates grown on CHROMagar Candida medium. J Clin Microbiol. 2002;40:4768–70.

    Article  PubMed  CAS  Google Scholar 

  16. Huang L, Chen C, Chou C, et al. A comparison of methods for yeast identification including CHROMagar Candida, vitek system YBC and a traditional biochemical method. Chin Med J. 2001;64:568–74.

    CAS  Google Scholar 

  17. Silva EH, Ruiz LS, Matsumoto FE, et al. Candiduria in a public hospital of São Paulo (1999–2004): characteristics of the yeast isolates. Rev Inst Med Trop S. Paulo. 2007;49:349–53.

    Article  PubMed  Google Scholar 

  18. Chou H-H, Lo H-J, Chen K-W, Liao M-H, Li S-Y. Multilocus sequence typing of Candida tropicalis shows clonal cluster enriched in isolates with resistance or trailing growth of fluconazole. Diagn Microbiol Infect Dis. 2007;58:427–33.

    Article  PubMed  CAS  Google Scholar 

  19. Mímica LMJ, Ueda SMY, Martino MDV, Navarini A, Martini IJ. Diagnóstico de infecção por Candida: avaliação de testes de identificação de espécies e caracterização do perfil de suscetibilidade. J Bras Patol Med Lab. 2009;45:17–23.

    Article  Google Scholar 

  20. Pinto PM, Weikert-Oliveira RCB, Lyon JP, et al. In vitro antifungal susceptibility of clinical isolates of Candida spp. obtained from patients with different predisposing factors to candidosis. Microbiol Res. 2008;163:579–85.

    Article  PubMed  CAS  Google Scholar 

  21. Lee SC, Lo HJ, Fung CP, Lee N, See LC. Disk diffusion test and E-test with enriched Mueller-Hinton agar for determining susceptibility of Candida species to voriconazole and fluconazole. J Microbiol Immunol Infect. 2009;42:148–53.

    PubMed  CAS  Google Scholar 

  22. Pfaller MA, Hazen KC, Messer SA, et al. Comparison of results of fluconazole disk diffusion testing for Candida species with results from a central reference laboratory in the ARTEMIS global antifungal surveillance program. J Clin Microbiol. 2004;42:3607–12.

    Article  PubMed  CAS  Google Scholar 

  23. Cheng MF, Yu KW, Tang RB, et al. Distribution and antifungal susceptibility of Candida species causing candidemia from 1996 to 1999. Diagn Microbiol Infect Dis. 2004;48:33–7.

    Article  PubMed  CAS  Google Scholar 

  24. Yang YL, Ho YA, Cheng HH, Ho M, Lo HJ. Susceptibilities of Candida species to amphotericin B and fluconazole: the emergence of fluconazole resistance in Candida tropicalis. Infect Control Hosp Epidemiol. 2004;25:60–4.

    Article  PubMed  CAS  Google Scholar 

  25. Yang YL, Ho YA, Cheng HH, Lo HJ. Distribution and susceptibility to amphotericin B and fluconazole of Candida spp. isolated from Taiwan. Epidemiol Infect. 2005;133:325–30.

    Article  PubMed  CAS  Google Scholar 

  26. Lee MK, Williams LE, Warnock DW, Arthington-Skaggs BA. Drug resistance genes and trailing growth in Candida albi-cans isolates. J Antimicrob Chemother. 2004;53:217–24.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

We acknowledge research grants from CNPq (National Scientific and Technological Research Council).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Antônio Alexandre de Vasconcelos Jr.

Rights and permissions

Reprints and permissions

About this article

Cite this article

de Vasconcelos, A.A., Menezes, E.A. & Cunha, F.A. Chromogenic Medium for Direct Susceptibility Testing of Candida spp. Isolated from Urine. Mycopathologia 172, 125–130 (2011). https://doi.org/10.1007/s11046-011-9407-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11046-011-9407-9

Keywords

Navigation